References
- RMLovell, ACFord. Global prevalence of, and risk factors for, irritable bowel syndrome: A meta-analysis. Clin Gastroenterol Hepatol 2012;10:712–21.
- GFLongstreth, WGThompson, WDChey, LAHoughton, FMearin, RCSpiller. Functional bowel disorders. Gastroenterology 2006;130:1480–91.
- American College of Gastroenterology IBSTF. An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol 2009;104:S1–7.
- RSpiller, QAziz, FEACreed, LHoughton, PHungin, RJones, et al. Guidelines on the irritable bowel syndrome: Mechanisms and practical management. Gut 2007;56:1770–98.
- LMBegtrup, ALEngsbro, JKjeldsen, PVLarsen, OSchaffalitzky de Muckadell, PBytzer, et al. A positive diagnostic strategy is noninferior to a strategy of exclusion for patients with irritable bowel syndrome. Clin Gastroenterol Hepatol 2013;11:956–62.
- DADrossman, WGThompson. The irritable bowel syndrome: Review and a graduated multicomponent treatment approach. Ann Intern Med 1992;116:1009–16.
- BMSpiegel, IMGralnek, RBolus, LChang, GSDulai, BNaliboff, et al. Is a negative colonoscopy associated with reassurance or improved health-related quality of life in irritable bowel syndrome? Gastrointest Endosc 2005;62:892–9.
- DSSanders, MJCarter, DPHurlstone, APearce, AMilford Ward, MEMcAlindon, et al. Association of adult coeliac disease with irritable bowel syndrome: A case-control study in patients fulfilling ROME II criteria referred to secondary care. Lancet 2001;358:1504–8.
- ACFord, WDChey, NJTalley, AMalhotra, BMRSpiegel, PMoayyedi. Yield of diagnostic tests for celiac disease in subjects with symptoms suggestive of irritable bowel syndrome: Systematic review and meta-analysis. Arch Intern Med 2009;169:651–8.
- LWedlake, RA’Hern, DRussell, KThomas, JRWalters, HJAndreyev. Systematic review: The prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2009;30:707–17.
- DJGracie, JSKane, SMumtaz, AFScarsbrook, FUChowdhury, ACFord. Prevalence of, and predictors of, bile acid malabsorption in outpatients with chronic diarrhea. Neurogastroenterol Motil 2012;24:983–e538.
- ABajor, AKilander, AFae, CGalman, OJonsson, LOhman, et al. Normal or increased bile acid uptake in isolated mucosa from patients with bile acid malabsorption. Eur J Gastroenterol Hepatol 2006;18:397–403.
- ALupascu, MGabrielli, ECLauritano, EScarpellini, ASantoliquido, GCammarota, et al. Hydrogen glucose breath test to detect small intestinal bacterial overgrowth: A prevalence case-control study in irritable bowel syndrome. Aliment Pharmacol Ther 2005;22:1157–60.
- ACFord, BMRSpiegel, NJTalley, PMoayyedi. Small intestinal bacterial overgrowth in irritable bowel syndrome: Systematic review and meta-analysis. Clin Gastroenterol Hepatol 2009;7:1279–86.
- ASainsbury, DSSanders, ACFord. Prevalence of irritable bowel syndrome-type symptoms in patients with celia disease: A meta-analysis. Clin Gastroenterol Hepatol 2012;11:359–65.
- SJHalpin, ACFord. Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: Systematic review and meta-analysis. Am J Gastroenterol 2012;107:1474–82.
- RAbboud, DSPardi, WJTremaine, PPKammer, WJSandborn, EVLoftusJr. Symptomatic overlap between microscopic colitis and irritable bowel syndrome: a prospective study. Inflamm Bowel Dis 2013;19:550–3.
- ACFord, PBercik, DGMorgan, CBolino, MIPintos-Sanchez, PMoayyedi. Validation of the Rome III criteria for the diagnosis of irritable bowel syndrome in secondary care. Gastroenterology 2013;145:1262–70.
- WDChey, BNojkov, JHRubenstein, RDobhan, JKGreenson, BDCash. The yield of colonoscopy in patients with non-constipated irritable bowel syndrome: Results from a prospective, controlled US trial. Am J Gastroenterol 2010;105:859–65.
- SIshihara, KYashima, YKushiyama, AIzumi, KKawashima, HFujishiro, et al. Prevalence of organic colonic lesions in patients meeting Rome III criteria for diagnosis of IBS: a prospective multi-center study utilizing colonoscopy. J Gastroenterol 2012;47:1084–90.
- ACFord, PBercik, DGMorgan, CBolino, MIPintos-Sanchez, PMoayyedi. The Rome III criteria for the diagnosis of functional dyspepsia in secondary care are not superior to previous definitions. Gastroenterology 2014;146:932–40.
- ACFord, PBercik, DGMorgan, CBolino, MIPintos-Sanchez, PMoayyedi. Characteristics of functional bowel disorder patients: A cross-sectional survey using the Rome III criteria. Aliment Pharmacol Ther 2014;39:312–21.
- WEWhitehead. and the Validation Working Team Committee in association with the Rome Questionnaire C. Development and validation of the Rome III diagnostic questionnaire. In DADrossman, editor. Rome III: The functional gastrointestinal disorders. 3rd edition. Virginia: Degnon Associates, Inc; 2006. p 835–53.
- DLimsui, DSPardi, MCamilleri, EVLoftus, PPKammer, WJTremaine, et al. Symptomatic overlap between irritable bowel syndrome and microscopic colitis. Inflamm Bowel Dis 2007;13:175–81.
- ACFord, SJOVeldhuyzen Van Zanten, CCRodgers, NJTalley, NBVakil, PMoayyedi. Diagnostic utility of alarm features for colorectal cancer: Systematic review and meta-analysis. Gut 2008;57:1545–53.
- ACFord, NJTalley, SJVeldhuyzen Van Zanten, NBVakil, DLSimel, PMoayyedi. Will the history and physical examination help establish that irritable bowel syndrome is causing this patient’s lower gastrointestinal tract symptoms? JAMA 2008;300:1793–805.